PEL

Piramal Enterprises Limited has informed the Exchange regarding the Schedule of Analyst/ Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Piramal Enterprises Limited has submitted the Exchange a copy of presentation on "Q3 FY2016".

Piramal Enterprises Limited has informed the Exchange regarding Contact details of Key Managerial Personnel as required under Regulation 30(5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Piramal Enterprises Limited has informed the Exchange regarding "Errata - Audited financial results for the year ended March 31, 2015.

Piramal Enterprises Limited has informed the Exchange that Mr. Ajay G. Piramal, Chairman of Piramal Enterprises Limited, has been appointed as the Non-Executive Chairman of Shriram Capital Limited at its Board Meeting held on November 15, 2014.

Piramal Enterprises Limited has submitted to the Exchange a copy of revised statement showing the consolidated segment results for the quarter and half year ended ended September 30, 2014.

Piramal Enterprises Limited has informed the Exchange that the Company has today agreed to acquire 65,79,840 equity shares in Shriram City Union Finance Limited ('SCUFL'), representing 9.99% of the post-diluted equity share capital of SCUFL, by way of subscription to fresh shares pursuant to a preferential allotment by SCUFL.

Piramal Enterprises Limited has informed the Exchange that the Order of the Court sanctioning the Scheme has been filed with the Registrar of Companies on 2nd July, 2013 and accordingly, the Scheme has become effective. The Appointed Date of the Scheme is January 1, 2013. In terms of the Scheme, 8,40,92,879 Equity Shares of the Company held by the Transferor i.e. PHL Holdings Private Limited (PHPL) stands cancelled and equivalent number of equity shares credited as fully paid up are to be issued and allotted by the Company to the equity shareholder of PHPL in lieu thereof.

Piramal Enterprises Limited has informed the Exchange that the "Hon'ble High Court of Judicature at Bombay has sanctioned the Scheme of Amalgamation and Arrangement between PHL Holdings Private Limited and Piramal Enterprises Limited and their respective shareholders and creditors by its order passed on May 10, 2013. While the authenticated copy of the Order has now been received, the certified copy of the order is awaited. Once the same is received and filed with the Registrar of Companies, Maharashtra, the Scheme will become effective".

Piramal Enterprises Limited has informed the Exchange that with reference to the earlier announcement dated May 10, 2013, whereby Piramal Enterprises Ltd. (PEL) had announced that PEL has acquired 2,28,47,468 equity shares of Shriram Transport Finance Company Limited (STFCL) representing approximately 10% of total equity share capital of STFCL, The Company has now informed the Exchanged that the actual number of equity shares acquired was 2,26,00,000 (and not 2,28,47,468) and necessary disclosure under SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011 was duly filed with

Piramal Enterprises Limited has informed the Exchange that the Company has on May 10, 2013 decided to acquire an approximately 10% equity stake in Shriram Transport Finance Company Limited ('Shriram Transport') through a block deal on the floor of the Stock Exchange.

Piramal Healthcare Limited has informed the Exchange vide its letter dated March 29, 2011 regarding "Buyback of 41,802,629 equity shares of Rs. 2/- each by Piramal Healthcare Limited through a Tender Offer at a Price of Rs. 600/- per share".

Piramal Healthcare Limited has informed the Exchange regarding a revised timeline for Buyback of 41,802,629 Equity Shares through a Tender Offer Route at a price of Rs. 600 per share.

Piramal Healthcare Limited has informed the Exchange with reference to the earlier Public Announcement dated December 09, 2010 regarding Buy Back of 41,802,629 equity shares through a Tender Offer Route at a price of Rs.600 per share that the Letter of Offer for the Buyback is in the process of finalisation and shall be dispatched once the Company have received the necessary regulatory clearances. Consequently, the Company will issue a Corrigendum to the PA ("Corrigendum") containing the revised timeline (including the Opening and Closing Dates) for the Buyback. The Corrigendum shall appear in

Piramal Healthcare Limited had informed the Exchange that the Company has signed a definitive agreement under which, Super Religare Laboratories Limited ('SRL') would acquire Piramal Diagnostic Services Private Limited ("PDSL"), a subsidiary of the Company. The Company has now informed the Exchange vide its letter dated August 21, 2010, that the Company has now completed the divestiture of its shareholding in PDSPL to SRL.

Piramal Healthcare Limited has informed the Exchange that "As a part of consolidation of global manufacturing assets, Piramal Healthcare has decided to discontinue operations at its manufacturing facility in Huddersfield, UK. This is an Intermediate/API site catering to the Pharma Solutions (Custom Manufacturing) business and is one of the manufacturing sites of Piramal Healthcare (UK) Ltd., the Company's wholly-owned subsidiary in the UK. In 2005, Piramal Healthcare acquired Avecia Pharmaceuticals which was then renamed as NPIL Pharmaceuticals (UK) Ltd. (now known as Piramal Healthcare (UK) L